FRX Bionik, LLC is a private investment fund based in New York, New York. According to its most recent Form D, filed Dec 6, 2018, it has sold $80,000 of interests to 3 investors since its first sale in Jan 2015. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include LLC Assure Fund Management II; LLC FundRx Capital Management; Richard Thoms.
- Total raised
- $80,000Cumulative sales reported on Form D
- Investors
- 3
- First sale
- Jan 21, 2015
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- LLC Assure Fund Management II; LLC FundRx Capital Management; Richard Thoms
- Latest Form D
- Dec 6, 2018
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about FRX Bionik, LLC
What is the minimum investment for FRX Bionik, LLC?
FRX Bionik, LLC's latest Form D, filed Dec 6, 2018, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in FRX Bionik, LLC?
FRX Bionik, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has FRX Bionik, LLC raised?
FRX Bionik, LLC reports $80,000 sold from 3 investors on its Form D filed Dec 6, 2018. This is cumulative sales since the offering began, not current assets or performance.
Where is FRX Bionik, LLC based?
FRX Bionik, LLC is based in New York, New York.
When did FRX Bionik, LLC launch?
FRX Bionik, LLC reports its first sale in Jan 2015.
Size compared with every private investment fund
Raised more than 22% of the 2,818 private investment funds based in New York, and more than 2% of all 10,263 that report sales.